Longevity · Longevity peptide (research)
MOTS-c
- Drug class
- Longevity peptide (research)
- Status
- Compounded (503A)
- Reviewed
- 2026-06-01 · Kindr Health Clinical Team
What MOTS-c is studied for
- Mitochondrial health (research)
- Metabolic regulation (research)
- Exercise capacity (research)
Mechanism of action
MOTS-c is being studied in the longevity category. Mitochondrial-derived peptide for metabolic regulation and exercise capacity. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is MOTS-c?
MOTS-c is a longevity peptide. Mitochondrial-derived peptide for metabolic regulation and exercise capacity.
What is MOTS-c studied for?
Published research has examined MOTS-c for mitochondrial health, metabolic regulation, exercise capacity. Human clinical evidence varies by indication.
Is MOTS-c FDA-approved?
No. MOTS-c is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is MOTS-c used in research?
Protocols vary by study. MOTS-c is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for MOTS-c is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.
Build the MOTS-c protocol stack
Research protocols commonly pair MOTS-c with the peptides below. Add all three vials to unlock the bundle discount at checkout.
Related peptides in Longevity
Continue across the Kindr entity graph
Related evidence, peptides, and clinical tools on the same topic.